eCFR Reference Browser

---

title: "21 CFR §516.24"

source: "https://www.ecfr.gov/current/title-21/section-516.24"

title_number: "21"

volume_number: "6"

chapter_number: "Unknown"

subchapter_code: "E"

subchapter_subject: "ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS"

part_code: "516"

part_subject: "NEW ANIMAL DRUGS FOR MINOR USE AND MINOR SPECIES"

subpart_code: "B"

subpart_subject: "Designation of a Minor Use or Minor Species New Animal Drug"

section_number: "516.24"

section_subject: "Granting MUMS-drug designation."

cfr_reference: "21 CFR 516.24"

title_name: "Title 21"

title_subject: "Food and Drugs"

parts_covered: "Parts 500 to 599"

revised_date: "Revised as of April 1, 2019"

publication_date: "As of April 1, 2019"

contains_description: "Containing a codification of documents of general applicability and future effect"

publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"

---

(a)FDA may grant the request for MUMS-drug designation if none of the reasons described in § 516.25 for refusal to grant such a request apply.

(b)When a request for MUMS-drug designation is granted, FDA will notify the sponsor in writing and will give public notice of the MUMS-drug designation in accordance with § 516.28.

§516.24 - Granting MUMS-drug designation.